On September 11, 2025, Phio Pharmaceuticals Corp. held its Annual Meeting where stockholders approved an increase of 950,000 shares to the 2020 Long Term Incentive Plan, totaling 1,023,017 shares available. Additionally, the stockholders elected six directors and ratified Grant Thornton as the independent auditor for 2025.